메뉴 건너뛰기




Volumn 9, Issue 7, 2012, Pages 382-391

Recent advances in our understanding of hepatorenal syndrome

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CYTOKINE; MIDODRINE; NORADRENALIN; OCTREOTIDE; PLACEBO; TERLIPRESSIN; VASOCONSTRICTOR AGENT;

EID: 84863427931     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.96     Document Type: Review
Times cited : (85)

References (97)
  • 1
    • 58149384525 scopus 로고    scopus 로고
    • Acute kidney injury in cirrhosis
    • Garcia-Tsao, G., Parikh, C. R. & Viola A. Acute kidney injury in cirrhosis. Hepatology 48, 2064-2077 (2008).
    • (2008) Hepatology , vol.48 , pp. 2064-2077
    • Garcia-Tsao, G.1    Parikh, C.R.2    Viola, A.3
  • 2
    • 84879619987 scopus 로고    scopus 로고
    • 11th edn (eds Schiff, E. R., Maddrey, W. C. & Sorrell, M. F.) Wiley-Blackwell
    • Wong, F. in Schiff's Diseases of the Liver 11th edn (eds Schiff, E. R., Maddrey, W. C. & Sorrell, M. F.) 354-371 (Wiley-Blackwell, 2011).
    • (2011) Schiff's Diseases of the Liver , pp. 354-371
    • Wong, F.1
  • 3
    • 0023749667 scopus 로고
    • Peripheral arterial vasodilatation hypo thesis a proposal for the initiation of renal sodium and water retention in cirrhosis
    • Schrier, R. et al. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151-1157 (1988).
    • (1988) Hepatology , vol.8 , pp. 1151-1157
    • Schrier, R.1
  • 4
    • 34548120893 scopus 로고    scopus 로고
    • Diagnosis prevention and treatment of hepatorenal syndrome in cirrhosis
    • Salerno, F., Gerbes, A., Ginès, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56, 1310-1318 (2007).
    • (2007) Gut , vol.56 , pp. 1310-1318
    • Salerno, F.1    Gerbes, A.2    Ginès, P.3    Wong, F.4    Arroyo, V.5
  • 5
    • 77953806441 scopus 로고    scopus 로고
    • Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites
    • Montoliu, S. et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin. Gastroenterol. Hepatol. 8, 616-622 (2010).
    • (2010) Clin. Gastroenterol. Hepatol. , vol.8 , pp. 616-622
    • Montoliu, S.1
  • 7
    • 0032551891 scopus 로고    scopus 로고
    • Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
    • Martin, P. Y., Ginès, P. & Schrier, R. W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N. Engl. J. Med. 339, 533-541 (1998).
    • (1998) N. Engl. J. Med. , vol.339 , pp. 533-541
    • Martin, P.Y.1    Ginès, P.2    Schrier, R.W.3
  • 8
    • 64749090789 scopus 로고    scopus 로고
    • Carbon monoxide produced by intrasinusoidally located haem oxygenase 1 regulates the vascular tone in cirrhotic rat liver
    • Van Landeghem, L. et al. Carbon monoxide produced by intrasinusoidally located haem oxygenase 1 regulates the vascular tone in cirrhotic rat liver. Liver Int. 29, 650-660 (2009).
    • (2009) Liver Int. , vol.29 , pp. 650-660
    • Van Landeghem, L.1
  • 9
    • 0036142225 scopus 로고    scopus 로고
    • Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
    • Ros, J. et al. Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122, 85-93 (2002).
    • (2002) Gastroenterology , vol.122 , pp. 85-93
    • Ros, J.1
  • 10
    • 0034928628 scopus 로고    scopus 로고
    • Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
    • Bátkai, S. et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7, 827-832 (2001).
    • (2001) Nat. Med. , vol.7 , pp. 827-832
    • Bátkai, S.1
  • 11
    • 0028138887 scopus 로고
    • Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis
    • Castro, A. et al. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. J. Hepatol. 21, 521-526 (1994).
    • (1994) J. Hepatol. , vol.21 , pp. 521-526
    • Castro, A.1
  • 12
    • 85027934056 scopus 로고    scopus 로고
    • Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis
    • Møller, S., Hobolth, L., Winkler, C., Bendtsen, F. & Christensen, E. Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 60, 1254-1259 (2011).
    • (2011) Gut , vol.60 , pp. 1254-1259
    • Møller, S.1    Hobolth, L.2    Winkler, C.3    Bendtsen, F.4    Christensen, E.5
  • 13
    • 0027973463 scopus 로고
    • Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
    • Follo, A. et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology 20, 1495-1501 (1994).
    • (1994) Hepatology , vol.20 , pp. 1495-1501
    • Follo, A.1
  • 14
    • 33846433657 scopus 로고    scopus 로고
    • Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features
    • Fasolato, S. et al. Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features. Hepatology 45, 223-229 (2007).
    • (2007) Hepatology , vol.45 , pp. 223-229
    • Fasolato, S.1
  • 15
    • 0026755224 scopus 로고
    • Endotoxin levels in cirrhotic rats with sterile and infected ascites
    • Sugano, S. Endotoxin levels in cirrhotic rats with sterile and infected ascites. Gastroenterol. Jpn 27, 348-353 (1992).
    • (1992) Gastroenterol. Jpn , vol.27 , pp. 348-353
    • Sugano, S.1
  • 16
    • 0033836743 scopus 로고    scopus 로고
    • Effects of lipopolysaccharide on TNF a production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
    • Heller, J. et al. Effects of lipopolysaccharide on TNF a production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J. Hepatol. 33, 376-381 (2000).
    • (2000) J. Hepatol. , vol.33 , pp. 376-381
    • Heller, J.1
  • 17
    • 0032696338 scopus 로고    scopus 로고
    • Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
    • Wiest, R. et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 104, 1223-1233 (1999).
    • (1999) J. Clin. Invest. , vol.104 , pp. 1223-1233
    • Wiest, R.1
  • 18
    • 0037219393 scopus 로고    scopus 로고
    • Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
    • Albillos, A. et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37, 208-217 (2003).
    • (2003) Hepatology , vol.37 , pp. 208-217
    • Albillos, A.1
  • 19
    • 22344434535 scopus 로고    scopus 로고
    • Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: Role of Akt signaling
    • Tazi, K. A. et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: Role of Akt signaling. Gastroenterology 129, 303-314 (2005).
    • (2005) Gastroenterology , vol.129 , pp. 303-314
    • Tazi, K.A.1
  • 20
    • 0034872638 scopus 로고    scopus 로고
    • Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis
    • Cejudo-Martín, P. et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 34, 487-493 (2001).
    • (2001) Hepatology , vol.34 , pp. 487-493
    • Cejudo-Martín, P.1
  • 21
    • 36348935694 scopus 로고    scopus 로고
    • Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
    • Fernandez, M. et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 46, 1208-1217 (2007).
    • (2007) Hepatology , vol.46 , pp. 1208-1217
    • Fernandez, M.1
  • 22
    • 77955853856 scopus 로고    scopus 로고
    • Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension
    • Bosch, J., Abraldes, J. G., Fernández, M. & García-Pagán, J. C. Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension. J. Hepatol. 53, 558-567 (2010).
    • (2010) J. Hepatol. , vol.53 , pp. 558-567
    • Bosch, J.1    Abraldes, J.G.2    Fernández, M.3    García-Pagán, J.C.4
  • 23
    • 59749085643 scopus 로고    scopus 로고
    • Cirrhotic cardiomyopathy
    • Wong, F. Cirrhotic cardiomyopathy. Hepatol. Int. 3, 294-304 (2009).
    • (2009) Hepatol. Int. , vol.3 , pp. 294-304
    • Wong, F.1
  • 24
    • 23044508419 scopus 로고    scopus 로고
    • Circulatory function and hepatorenal syndrome in cirrhosis
    • Ruiz del Arbol, L. et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42, 439-447 (2005).
    • (2005) Hepatology , vol.42 , pp. 439-447
    • Ruiz Del Arbol, L.1
  • 25
    • 73449112667 scopus 로고    scopus 로고
    • Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
    • Krag, A., Bendtsen, F., Henriksen, J. H. & Møller, S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 59, 105-110 (2010).
    • (2010) Gut , vol.59 , pp. 105-110
    • Krag, A.1    Bendtsen, F.2    Henriksen, J.H.3    Møller, S.4
  • 26
    • 0142244899 scopus 로고    scopus 로고
    • Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
    • Ruiz del Arbol, L. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38, 1210-1218 (2003).
    • (2003) Hepatology , vol.38 , pp. 1210-1218
    • Ruiz Del Arbol, L.1
  • 27
    • 37349124906 scopus 로고    scopus 로고
    • Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis
    • Stadlbauer, V. et al. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology 134, 111-119 (2008).
    • (2008) Gastroenterology , vol.134 , pp. 111-119
    • Stadlbauer, V.1
  • 28
    • 81355138638 scopus 로고    scopus 로고
    • Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice
    • Salerno, F. et al. Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice. J. Hepatol. 55, 1241-1248 (2011).
    • (2011) J. Hepatol. , vol.55 , pp. 1241-1248
    • Salerno, F.1
  • 29
    • 0020395710 scopus 로고
    • Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study
    • Mandal, A. K., Lansing, M. & Fahmy, A. Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study. Am. J. Kidney Dis. 2, 363-374 (1982).
    • (1982) Am. J. Kidney Dis. , vol.2 , pp. 363-374
    • Mandal, A.K.1    Lansing, M.2    Fahmy, A.3
  • 30
    • 77954379963 scopus 로고    scopus 로고
    • The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study
    • Trawalé, J. M. et al. The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study. Liver Int. 30, 725-732 (2010).
    • (2010) Liver Int. , vol.30 , pp. 725-732
    • Trawalé, J.M.1
  • 32
    • 0020060933 scopus 로고
    • Aminoglycoside nephrotoxicity in cirrhosis value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage
    • Cabrera, J. et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82, 97-105 (1982).
    • (1982) Gastroenterology , vol.82 , pp. 97-105
    • Cabrera, J.1
  • 33
    • 0031863011 scopus 로고    scopus 로고
    • Ischemic renal diseases: New insights into old entities
    • Meyrier, A., Hill, G. S. & Simon, P. Ischemic renal diseases: New insights into old entities. Kidney Int. 54, 2-13 (1998).
    • (1998) Kidney Int. , vol.54 , pp. 2-13
    • Meyrier, A.1    Hill, G.S.2    Simon, P.3
  • 34
    • 42949122561 scopus 로고    scopus 로고
    • Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites
    • Sersté, T., Lebrec, D., Valla, D. & Moreau, R. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites. Acta Gastroenterol. Belg. 71, 9-14 (2008).
    • (2008) Acta Gastroenterol. Belg. , vol.71 , pp. 9-14
    • Sersté, T.1    Lebrec, D.2    Valla, D.3    Moreau, R.4
  • 35
    • 79953093468 scopus 로고    scopus 로고
    • Acute on chronic liver failure: From concept to a new syndrome
    • Jalan, R. Acute on chronic liver failure: From concept to a new syndrome. Curr. Opin. Crit. Care 17, 152 (2011).
    • (2011) Curr. Opin. Crit. Care , vol.17 , pp. 152
    • Jalan, R.1
  • 36
    • 79953116158 scopus 로고    scopus 로고
    • Acute on chronic liver failure: Concept, natural history, and prognosis
    • Olsen, J. C. & Kamath, P. S. Acute on chronic liver failure: Concept, natural history, and prognosis. Curr. Opin. Crit. Care 17, 165-169 (2011).
    • (2011) Curr. Opin. Crit. Care , vol.17 , pp. 165-169
    • Olsen, J.C.1    Kamath, P.S.2
  • 38
    • 40149103666 scopus 로고    scopus 로고
    • Pathogenesis and treatment of hepatorenal syndrome
    • Arroyo, V., Fernandez, J. & Ginès, P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis. 28, 81-95 (2008).
    • (2008) Semin. Liver Dis. , vol.28 , pp. 81-95
    • Arroyo, V.1    Fernandez, J.2    Ginès, P.3
  • 39
    • 84863484199 scopus 로고    scopus 로고
    • Is type 1 hepatorenal syndrome reversible after liver transplantation? [abstract 653
    • Leung, W., Al Beshir, M., Marquez, M., Renner, E. & Wong, F. Is type 1 hepatorenal syndrome reversible after liver transplantation? [abstract 653]. J. Hepatol. 56 (Suppl. 2), S258-S259 (2012).
    • (2012) J. Hepatol. , vol.56 , Issue.SUPPL. 2
    • Leung, W.1    Al Beshir, M.2    Marquez, M.3    Renner, E.4    Wong, F.5
  • 40
    • 59849122428 scopus 로고    scopus 로고
    • Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: A retrospective study
    • Terg, R. et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: A retrospective study. Liver Int. 29, 415-419 (2009).
    • (2009) Liver Int. , vol.29 , pp. 415-419
    • Terg, R.1
  • 41
    • 34147202689 scopus 로고    scopus 로고
    • Restricted use of albumin for spontaneous bacterial peritonitis
    • Sigal, S. H., Stanca, C. M., Fernández, J., Arroyo, V. & Navasa, M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 56, 597-599 (2007).
    • (2007) Gut , vol.56 , pp. 597-599
    • Sigal, S.H.1    Stanca, C.M.2    Fernández, J.3    Arroyo, V.4    Navasa, M.5
  • 42
    • 84857192662 scopus 로고    scopus 로고
    • Role of albumin in the treatment in patients with spontaneous bacterial peritonitis
    • Poca, M. et al. Role of albumin in the treatment in patients with spontaneous bacterial peritonitis. Clin. Gastroenterol. Hepatol. 10, 309-315 (2012).
    • (2012) Clin. Gastroenterol. Hepatol. , vol.10 , pp. 309-315
    • Poca, M.1
  • 43
    • 0033527033 scopus 로고    scopus 로고
    • Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
    • Sort, P. et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403-409 (1999).
    • (1999) N. Engl. J. Med. , vol.341 , pp. 403-409
    • Sort, P.1
  • 44
    • 79961209982 scopus 로고    scopus 로고
    • Meta-Analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-An updated Cochrane review
    • Chavez-Tapia, N. C. et al. Meta-Analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-An updated Cochrane review. Aliment. Pharmacol. Ther. 34, 509-518 (2011).
    • (2011) Aliment. Pharmacol. Ther. , vol.34 , pp. 509-518
    • Chavez-Tapia, N.C.1
  • 45
    • 61549143389 scopus 로고    scopus 로고
    • Pharmacology clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome
    • Saner, F. H., Canbay, A., Gerken, G. & Broelsch, C. E. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev. Gastroenterol. Hepatol. 1, 207-217 (2007).
    • (2007) Expert Rev. Gastroenterol. Hepatol. , vol.1 , pp. 207-217
    • Saner, F.H.1    Canbay, A.2    Gerken, G.3    Broelsch, C.E.4
  • 46
    • 0025007486 scopus 로고
    • A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices
    • Chiu, K. W., Sheen, I. S. & Liaw, Y. F. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices. J. Gastroenterol. Hepatol. 5, 549-553 (1990).
    • (1990) J. Gastroenterol. Hepatol. , vol.5 , pp. 549-553
    • Chiu, K.W.1    Sheen, I.S.2    Liaw, Y.F.3
  • 47
    • 42949104076 scopus 로고    scopus 로고
    • A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome
    • Sanyal, A. J. et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134, 1360-1368 (2008).
    • (2008) Gastroenterology , vol.134 , pp. 1360-1368
    • Sanyal, A.J.1
  • 48
    • 42949160648 scopus 로고    scopus 로고
    • Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study
    • Martín-Llahí, M. et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology 134, 1352-1359 (2008).
    • (2008) Gastroenterology , vol.134 , pp. 1352-1359
    • Martín-Llahí, M.1
  • 49
    • 79960450415 scopus 로고    scopus 로고
    • Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
    • Boyer, T. D. et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics. J. Hepatol. 55, 315-321 (2011).
    • (2011) J. Hepatol. , vol.55 , pp. 315-321
    • Boyer, T.D.1
  • 50
    • 73449116381 scopus 로고    scopus 로고
    • Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
    • Nazar, A. et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 51, 219-226 (2010).
    • (2010) Hepatology , vol.51 , pp. 219-226
    • Nazar, A.1
  • 51
    • 33846074784 scopus 로고    scopus 로고
    • Drug insight: The role of albumin in the management of chronic liver disease
    • Wong, F. Drug insight: The role of albumin in the management of chronic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 43-51 (2007).
    • (2007) Nat. Clin. Pract. Gastroenterol. Hepatol. , vol.4 , pp. 43-51
    • Wong, F.1
  • 52
  • 53
    • 84872213242 scopus 로고    scopus 로고
    • Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: Results of a controlled clinical trial [abstract LB3]
    • Angeli, P. et al. Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: Results of a controlled clinical trial [abstract LB3]. Hepatology 48 (Suppl.), 378A (2008).
    • (2008) Hepatology , vol.48 A378 , Issue.SUPPL.
    • Angeli, P.1
  • 54
    • 69249141116 scopus 로고    scopus 로고
    • Terlipressin for hepatorenal syndrome: Continuous infusion as an alternative to iv bolus administration
    • Gerbes, A. L., Huber, E. & Gülberg, V. Terlipressin for hepatorenal syndrome: Continuous infusion as an alternative to i.v. bolus administration. Gastroenterology 137, 1179-1181 (2009).
    • (2009) Gastroenterology , vol.137 , pp. 1179-1181
    • Gerbes, A.L.1    Huber, E.2    Gülberg, V.3
  • 55
    • 0031058016 scopus 로고    scopus 로고
    • Time profile of the haemodynamic effects of terlipressin in portal hypertension
    • Escorsell, A. et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J. Hepatol. 26, 621-627 (1997).
    • (1997) J. Hepatol. , vol.26 , pp. 621-627
    • Escorsell, A.1
  • 56
    • 79960469956 scopus 로고    scopus 로고
    • Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation
    • Piano, S. et al. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? J. Hepatol. 55, 491-496 (2011).
    • (2011) J. Hepatol. , vol.55 , pp. 491-496
    • Piano, S.1
  • 57
    • 0033065188 scopus 로고    scopus 로고
    • Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
    • Angeli, P. et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29, 1690-1697 (1999).
    • (1999) Hepatology , vol.29 , pp. 1690-1697
    • Angeli, P.1
  • 58
    • 3042696433 scopus 로고    scopus 로고
    • Midodrine octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
    • Wong, F., Pantea, L. & Sniderman, K. Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40, 55-64 (2004).
    • (2004) Hepatology , vol.40 , pp. 55-64
    • Wong, F.1    Pantea, L.2    Sniderman, K.3
  • 59
    • 33847179154 scopus 로고    scopus 로고
    • Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome
    • Esrailian, E., Pantangco, E. R., Kyulo, N. L., Hu, K. Q. & Runyon, B. A. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig. Dis. Sci. 52, 742-748 (2007).
    • (2007) Dig. Dis. Sci. , vol.52 , pp. 742-748
    • Esrailian, E.1    Pantangco, E.R.2    Kyulo, N.L.3    Hu, K.Q.4    Runyon, B.A.5
  • 60
    • 84872205818 scopus 로고    scopus 로고
    • Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: Results of a controlled clinical trial by the Italian Association for the Study of the Liver [abstract LB 2
    • Cavallin, M. et al. Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: Results of a controlled clinical trial by the Italian Association for the Study of the Liver [abstract LB 2]. Hepatology 54 (Suppl. 1), 1426A (2011).
    • (2011) Hepatology , vol.54 , Issue.SUPPL. 1
    • Cavallin, M.1
  • 61
    • 79955627076 scopus 로고    scopus 로고
    • Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin
    • Rice, J. P., Skagen, C. & Said, A. Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin. Transplantation 91, 1141-1147 (2011).
    • (2011) Transplantation , vol.91 , pp. 1141-1147
    • Rice, J.P.1    Skagen, C.2    Said, A.3
  • 62
    • 50649122545 scopus 로고    scopus 로고
    • An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response
    • Sharma, P., Kumar, A., Shrama, B. C. & Sarin, S. K. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am. J. Gastroenterol. 103, 1689-1697 (2008).
    • (2008) Am. J. Gastroenterol. , vol.103 , pp. 1689-1697
    • Sharma, P.1    Kumar, A.2    Shrama, B.C.3    Sarin, S.K.4
  • 63
    • 34548266811 scopus 로고    scopus 로고
    • Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
    • Alessandria, C. et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study. J. Hepatol. 47, 499-505 (2007).
    • (2007) J. Hepatol. , vol.47 , pp. 499-505
    • Alessandria, C.1
  • 64
    • 84863393358 scopus 로고    scopus 로고
    • Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: A randomized study
    • Singh, V. et al. Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: A randomized study. J. Hepatol. http://dx.doi.org/10.1016/ j.jhep.2012.01.012.
    • J. Hepatol.
    • Singh, V.1
  • 65
    • 75449112998 scopus 로고    scopus 로고
    • Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
    • Gluud, L. L., Christensen, K., Christensen, E. & Krag, A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51, 576-584 (2010).
    • (2010) Hepatology , vol.51 , pp. 576-584
    • Gluud, L.L.1    Christensen, K.2    Christensen, E.3    Krag, A.4
  • 66
    • 77951757909 scopus 로고    scopus 로고
    • Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-Analysis of randomized controlled trials
    • Sagi, S. V., Mittal, S., Kasturi, K. S. & Sood, G. K. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-Analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 25, 880-885 (2010).
    • (2010) J. Gastroenterol. Hepatol. , vol.25 , pp. 880-885
    • Sagi, S.V.1    Mittal, S.2    Kasturi, K.S.3    Sood, G.K.4
  • 67
    • 0042429572 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
    • Guevara, M. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems. Hepatology 28, 416-422 (1998).
    • (1998) Hepatology , vol.28 , pp. 416-422
    • Guevara, M.1
  • 68
    • 0031035980 scopus 로고    scopus 로고
    • Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome
    • Brensing, K. A. et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349, 697-698 (1997).
    • (1997) Lancet , vol.349 , pp. 697-698
    • Brensing, K.A.1
  • 69
    • 0033931614 scopus 로고    scopus 로고
    • Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
    • Brensing, K. A. et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study. Gut 47, 288-295 (2000).
    • (2000) Gut , vol.47 , pp. 288-295
    • Brensing, K.A.1
  • 70
    • 0037230428 scopus 로고    scopus 로고
    • Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis
    • Jalan, R. et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J. Hepatol. 38, 24-31 (2003).
    • (2003) J. Hepatol. , vol.38 , pp. 24-31
    • Jalan, R.1
  • 71
    • 25144450974 scopus 로고    scopus 로고
    • Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure
    • Di Campli, C. et al. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. Transplant. Proc. 37, 2547-2550 (2005).
    • (2005) Transplant. Proc. , vol.37 , pp. 2547-2550
    • Di Campli, C.1
  • 72
    • 0034109694 scopus 로고    scopus 로고
    • Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial
    • Mitzner, S. R. et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl. 6, 277-286 (2000).
    • (2000) Liver Transpl. , vol.6 , pp. 277-286
    • Mitzner, S.R.1
  • 73
    • 77749318513 scopus 로고    scopus 로고
    • Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment
    • Wong, F., Raina, N. & Richardson, R. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Gut 59, 381-386 (2010).
    • (2010) Gut , vol.59 , pp. 381-386
    • Wong, F.1    Raina, N.2    Richardson, R.3
  • 74
    • 0030877447 scopus 로고    scopus 로고
    • Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis
    • Ruiz del Arbol, L. et al. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 113, 579-586 (1997).
    • (1997) Gastroenterology , vol.113 , pp. 579-586
    • Ruiz del Arbol, L.1
  • 75
    • 0036787604 scopus 로고    scopus 로고
    • Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
    • Ortega, R. et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study. Hepatology 36, 941-948 (2002).
    • (2002) Hepatology , vol.36 , pp. 941-948
    • Ortega, R.1
  • 76
    • 0344099365 scopus 로고    scopus 로고
    • Type 2 hepatorenal syndrome and refractory ascites: Role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation
    • Testino, G. et al. Type 2 hepatorenal syndrome and refractory ascites: Role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50, 1753-1755 (2003).
    • (2003) Hepatogastroenterology , vol.50 , pp. 1753-1755
    • Testino, G.1
  • 77
    • 0036932433 scopus 로고    scopus 로고
    • Renal failure in cirrhotic patients: Role of terlipressin in clinical approach to hepatorenal syndrome type 2
    • Alessandria, C., Venon, W. & Marzano, A. Renal failure in cirrhotic patients: Role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur. J. Gastroenterol. Hepatol. 14, 1363-1368 (2002).
    • (2002) Eur. J. Gastroenterol. Hepatol. , vol.14 , pp. 1363-1368
    • Alessandria, C.1    Venon, W.2    Marzano, A.3
  • 78
    • 0344951290 scopus 로고    scopus 로고
    • Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis
    • Cassinello, C. et al. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig. Dis. Sci. 48, 179-186 (2003).
    • (2003) Dig. Dis. Sci. , vol.48 , pp. 179-186
    • Cassinello, C.1
  • 79
    • 0037223652 scopus 로고    scopus 로고
    • Model for end-stage liver disease (MELD) and allocation of donor livers
    • Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91-96 (2003).
    • (2003) Gastroenterology , vol.124 , pp. 91-96
    • Wiesner, R.1
  • 80
    • 85027940113 scopus 로고    scopus 로고
    • Impact of hepatorenal syndrome and liver transplantation
    • Memon, I. & Klein, C. L. Impact of hepatorenal syndrome and liver transplantation. Curr. Opin. Organ. Transplant. 16, 301-305 (2011).
    • (2011) Curr. Opin. Organ. Transplant. , vol.16 , pp. 301-305
    • Memon, I.1    Klein, C.L.2
  • 81
    • 0348103707 scopus 로고    scopus 로고
    • Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome A case-control study
    • Restuccia, T. et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J. Hepatol. 40, 140-146 (2004).
    • (2004) J. Hepatol. , vol.40 , pp. 140-146
    • Restuccia, T.1
  • 82
    • 82955161556 scopus 로고    scopus 로고
    • Hepatorenal syndrome, pharmacological therapy, and liver transplantation
    • Ginès, P. Hepatorenal syndrome, pharmacological therapy, and liver transplantation. Liver Transpl. 17, 1244-1246 (2011).
    • (2011) Liver Transpl. , vol.17 , pp. 1244-1246
    • Ginès, P.1
  • 83
    • 24944502810 scopus 로고    scopus 로고
    • Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
    • Wong, L. P. et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 68, 362-370 (2005).
    • (2005) Kidney Int. , vol.68 , pp. 362-370
    • Wong, L.P.1
  • 84
    • 31544469480 scopus 로고    scopus 로고
    • The course of type 1 hepatorenal syndrome post liver transplantation
    • Marik, P. E., Wood, K. & Starzl, T. E. The course of type 1 hepatorenal syndrome post liver transplantation. Nephrol. Dial. Transplant. 21, 478-482 (2006).
    • (2006) Nephrol. Dial. Transplant. , vol.21 , pp. 478-482
    • Marik, P.E.1    Wood, K.2    Starzl, T.E.3
  • 85
    • 0027450547 scopus 로고
    • Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients
    • Hadengue, A. et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 17, 175-178 (1993).
    • (1993) Hepatology , vol.17 , pp. 175-178
    • Hadengue, A.1
  • 86
    • 34249086997 scopus 로고    scopus 로고
    • Simultaneous liver-kidney transplantation: Evaluation to decision making
    • Davis, C. L. et al. Simultaneous liver-kidney transplantation: Evaluation to decision making. Am. J. Transplant. 7, 1702-1709 (2007).
    • (2007) Am. J. Transplant. , vol.7 , pp. 1702-1709
    • Davis, C.L.1
  • 88
    • 42149182370 scopus 로고    scopus 로고
    • Declining outcomes in simultaneous liver-kidney transplantation in the meld era: Ineffective usage of renal allografts
    • Locke, J. E. et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts. Transplantation 85, 935-942 (2008).
    • (2008) Transplantation , vol.85 , pp. 935-942
    • Locke, J.E.1
  • 89
    • 34250172894 scopus 로고    scopus 로고
    • Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT)
    • Ruiz, R. et al. Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT). Liver Transpl. 13, 838-843 (2007).
    • (2007) Liver Transpl. , vol.13 , pp. 838-843
    • Ruiz, R.1
  • 90
    • 69949186234 scopus 로고    scopus 로고
    • Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease
    • Somsouk, M. et al. Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment. Pharmacol. Ther. 30, 741-748 (2009).
    • (2009) Aliment. Pharmacol. Ther. , vol.30 , pp. 741-748
    • Somsouk, M.1
  • 91
    • 79551470420 scopus 로고    scopus 로고
    • Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk
    • Somsouk, M., Kornfield, R., Vittinghoff, E., Inadomi, J. M. & Biggins, S. W. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl. 17, 129-136 (2011).
    • (2011) Liver Transpl. , vol.17 , pp. 129-136
    • Somsouk, M.1    Kornfield, R.2    Vittinghoff, E.3    Inadomi, J.M.4    Biggins, S.W.5
  • 92
    • 34548487937 scopus 로고    scopus 로고
    • Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis
    • Fernández, J. et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133, 818-824 (2007).
    • (2007) Gastroenterology , vol.133 , pp. 818-824
    • Fernández, J.1
  • 93
    • 77951792200 scopus 로고    scopus 로고
    • Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis
    • Lebrec, D. et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 138, 1755-1762 (2010).
    • (2010) Gastroenterology , vol.138 , pp. 1755-1762
    • Lebrec, D.1
  • 94
    • 0034465251 scopus 로고    scopus 로고
    • Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    • Akriviadis, E. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial. Gastroenterology 119, 1637-1648 (2000).
    • (2000) Gastroenterology , vol.119 , pp. 1637-1648
    • Akriviadis, E.1
  • 96
    • 0027252834 scopus 로고
    • Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency
    • Lake, J. R. et al. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant. Proc. 25, 1766-1767 (1993).
    • (1993) Transplant. Proc. , vol.25 , pp. 1766-1767
    • Lake, J.R.1
  • 97
    • 0029010937 scopus 로고
    • Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt
    • Spahr, L. et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am. J. Gastroenterol. 90, 1169-1171 (1995).
    • (1995) Am. J. Gastroenterol. , vol.90 , pp. 1169-1171
    • Spahr, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.